Revolution Medicines, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Revolution Medicines, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2020 to Q3 2024.
  • Revolution Medicines, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $74.3M, a 39.9% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $74.3M +$21.2M +39.9% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $75.3M +$21.6M +40.1% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $76.2M +$21.9M +40.3% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $77.1M +$22.1M +40.1% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $53.1M -$3.14M -5.58% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $53.7M -$3.7M -6.44% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $54.3M -$4.27M -7.29% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $55.1M -$4.62M -7.73% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $56.3M +$31M +123% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $57.4M +$31.5M +122% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $58.6M +$31.9M +119% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $59.7M +$32.3M +118% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $25.2M -$2.96M -10.5% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $25.9M -$2.97M -10.3% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $26.7M +$18.2M +215% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $27.4M Dec 31, 2020 10-K 2022-02-28
Q3 2020 $28.2M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $28.9M Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $8.47M Mar 31, 2020 10-Q 2020-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.